GRIN Therapeutics

Operator of a biopharmaceutical company intended to develop precision therapies for pediatric neurodevelopmental disorders caused by mutations in the GRIN genes. The company specializes in assessing t...

Healthcare

New York, NY, United States

Founded 2021

4 employees

Website

Valuation

$445M

Market implied

Share Price

N/A

Total Raised

$275M

Last Round

N/A

Investors

+2 other investors

View all 2 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock GRIN Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required